AANS/CNS Section on Tumors I

The Section Sessions include oral presentations of top-rated abstracts, announcements of awards, lectures from accomplished speakers and moderated discussions on current topics.

Check back throughout the year as new topics, speakers and presentations are announced for this session.

Tuesday, April 28
2:00 pm - 5:30 pm
Location:

Moderator(s): Melanie Hayden Gephart, MD, FAANS; Pamela Stuart Jones, MD, MPH; John Y.K. Lee, MD, FAANS; Gabriel Zada, MD, FAANS


2:00 pm - 2:03 pm

Introduction to the Session

Melanie Hayden Gephart, MD, FAANS

2:04 pm - 2:20 pm

Treatment of Solitary Brain Metastases

Bruce E. Pollock, MD, FAANS

2:55 pm - 3:11 pm

Optimal Treatment of Small Meningiomas and Schwannomas

Gordon Ho-Wan Li, MD, FAANS

3:29 pm - 3:58 pm

Beverage Break in the Exhibit Hall

3:59 pm - 4:08 pm

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial

Joseph Paul Antonios, MD

4:09 pm - 4:18 pm

Protein Decrowding ExM For Discovery Of Previously Unidentified Structures And Cell Populations In Gliomas

Pablo Valdes Quevedo, MD

4:19 pm - 4:28 pm

Oncolytic Viral Delivery Into The Surgical Resection Cavity For The Treatment Of Glioblastoma In A Murine Model

Sricharan Gopakumar

4:29 pm - 4:38 pm

IDH-Mutant Gliomas Differ in Distribution of Mitochondrial Genomic Alterations

Koray Ozduman, MD, IFAANS (Turkey)

4:39 pm - 4:48 pm

Automated Intraoperative Frozen Diagnosis of Brain Tumors Using Machine Learning

Siri Sahib Singh Khalsa, MD

4:49 pm - 4:58 pm

Successful Clinical Trial of Chronic Convection-Enhanced Drug Delivery Via an Implanted Pump

Jeffrey N. Bruce, MD, FAANS

4:59 pm - 5:02 pm

Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.

Ashish Shah, MD

5:03 pm - 5:06 pm

Glioma-Neuronal Interactions: a study of tumor integration and synaptogenesis mediated language plasticity in adult high-grade glioma

Anthony Lee, MD

5:07 pm - 5:10 pm

Treatment of Recurrent Glioblastoma with Activated T cells Against Glioma Stem Cell Antigen Epitopes Leads to Antigen Specific and Cancer Stem Cell Killing

Angelique Sao-Mai S. Do, MD

5:11 pm - 5:14 pm

Data-driven Analytics Interrogates Surgical Performance using Novel Haptic Device

Garnette Roy Sutherland, MD, FAANS(L), FRCSC (Canada)

5:15 pm - 5:18 pm

Vaccination With Irradiated Whole Tumor Cells Pulsed With Phagocytic Agonists, TLR Ligands And Anti-CD40 Antibody Stimulates Antitumor Immune Response Against Metastatic And CNS Tumors

Rogelio Medina

5:19 pm - 5:22 pm

GBP2 as a Novel Promoter for Glioblastoma Invasion

Clark C. Chen, MD, PhD, FAANS

5:23 pm - 5:26 pm

Diagnostic Yield of Biopsy in Corticosteroid Pre-Treated Patients with Primary Central Nervous System Lymphoma

Florian Scheichel (Austria)

5:27 pm - 5:30 pm

Immunogenomic Responder Phenotype from a Phase I Trial of Anti-LAG3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM

Christina Chen-Jackson, MD